New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
STRATA Skin Sciences, Inc.
SSKN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

11M

Medical - Devices

Next Earning date - 12 Nov 2024

11M

Medical - Devices

Next Earning date - 12 Nov 2024

2.71USD
Shape-0.06 ( -2.17%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

18%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated October 3, 2024
1W -8.14 % 1M -10.56 % 3M -12.30 % 1Y -54.07 %

Key Metrics

Shape
  • Market Cap

    11.30M


  • Shares Outstanding

    4.17M


  • Share in Float

    2.46M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    2.71


  • Average Volume

    26652


  • Beta

    1.369


  • Range

    2.51-7.1


  • Industry

    Medical - Devices


  • Website

    https://www.strataskinsciences.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.35x

P/S Ratio

1.00x

P/B Ratio

1.6

Debt/Equity

-25.4%

Net Margin

$-2.4

EPS

How SSKN compares to sector?

P/E Ratio

Relative Strength

Shape

SSKN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$34M

Shape303%

2025-Revenue

$1.47

Shape-5113%

2025-EPS

$489K

Shape-42%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Zacks Investment Research

downgrade

Previous: Not converted

2022-04-26

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.30
vs -0.20

Q4.22

arrow
arrow

N/A

-0.05
vs -0.20

Q1.23

arrow
arrow

N/A

-0.80
vs -0.70

Q2.23

arrow
arrow

N/A

-0.90
vs -0.50

Q3.23

arrow
arrow

N/A

-0.30
vs -0.30

Q4.23

arrow
arrow

N/A

-0.40
vs -0.05

Q1.24

arrow
arrow

N/A

-1.00
vs -0.80

Q2.24

arrow
arrow

N/A

-0.03
vs -0.90

Q3.24

arrow
arrow

N/A

-0.44
vs -0.30

Q4.24

arrow
arrow

N/A

-0.43
vs -0.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+22%

9.4M  vs 7.7M

Q4.22

arrow
arrow

-27%

10.6M  vs 14.6M

Q1.23

arrow
arrow

+7%

7.6M  vs 7M

Q2.23

arrow
arrow

-9%

8.3M  vs 9.1M

Q3.23

arrow
arrow

-6%

8.9M  vs 9.4M

Q4.23

arrow
arrow

-18%

8.7M  vs 10.6M

Q1.24

arrow
arrow

-11%

6.8M  vs 7.6M

Q2.24

arrow
arrow

+2%

8.4M  vs 8.3M

Q3.24

arrow
arrow

-4%

8.5M  vs 8.9M

Q4.24

arrow
arrow

+4%

9M  vs 8.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.08

Q4.22

arrow
arrow

-1%

-0.01
vs -0.05

Q1.23

arrow
arrow

-15%

-0.15
vs -0.01

Q2.23

arrow
arrow

-19%

-0.19
vs -0.15

Q3.23

arrow
arrow

-7%

-0.07
vs -0.19

Q4.23

arrow
arrow

-30%

-0.30
vs -0.07

Q1.24

arrow
arrow

-36%

-0.36
vs -0.30

Q2.24

arrow
arrow

-1%

-0.01
vs -0.36

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

20

20
vs 22

-9%

Q4.22

arrow
arrow

29

29
vs 20

45%

Q1.23

arrow
arrow

27

27
vs 29

-7%

Q2.23

arrow
arrow

27

27
vs 27

NA

Q3.23

arrow
arrow

27

27
vs 27

NA

Q4.23

arrow
arrow

25

25
vs 27

-7%

Q1.24

arrow
arrow

22

22
vs 25

-12%

Q2.24

arrow
arrow

1

1
vs 22

-95%

Earnings Growth

Latest News